Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Remote care may cut stroke risk — a small trial puts it to the test

NCT ID NCT07124728

Disease control Sponsor: Syntrillo, Inc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This trial tests whether a 6-month telehealth program can reduce stroke risk factors, especially high blood pressure, in people already at elevated risk. Participants receive personalized remote care including blood pressure monitoring, wearable tracking, and virtual visits with a care team. The study aims to see if systolic blood pressure drops by at least 10 mmHg over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a 6-month telehealth program combining remote blood pressure monitoring, wearable tracking, and multidisciplinary care via a digital platform
What this could lead to
If it works, this could offer a scalable way to reduce stroke risk through remote care, especially for people with hypertension and other risk factors.
What could go wrong
This is a very small, single-arm study with only 11 participants, so results may not apply broadly. The program's success depends on patient engagement and technology access.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

11 people

The number who actually took part.

Started

Jul 2025

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age greater than or equal to 30 * Diagnosis of hypertension * One or more of the following: * Dtrial fibrillation * Diabetes * Chronic kidney disease (stage 2+) * Obesity (class 2+) * Obstructive sleep apnea * Coronary artery disease * Hyperlipidemia * Carotid stenosis (greater than or equal to 50%) * Congestive heart failure Exclusion Criteria: * History of stroke or TIA * Inability to consent or understand study * Residence in long-term acute care facility * Inability to ambulate independently * Non-English speaking * No internet access * Not residing in Virginia * Pregnancy or suspected pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular risk factor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder Inflammation stroke disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular risk factor Hypertension Hypertension (HTN) Stroke prevention

Contacts and locations

Locations

  • Syntrillo, Inc

    Charlottesville, Virginia, 22902, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.